GS
BIIB icon

GAM Systematic’s Biogen BIIB Stock Holding History

GAM Systematic’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.68M Buy
5,369
+1,688
+46% +$500K 0.24% 149
2017
Q2 		$999K Sell
3,681
-257
-7% -$68K 0.14% 287
2017
Q1 		$1.08M Buy
3,938
+1,639
+71% +$463K 0.21% 184
2016
Q4 		$652K Sell
2,299
-21
-0.9% -$6.22K 0.15% 272
2016
Q3 		$726K Buy
2,320
+1,614
+229% +$478K 0.15% 278
2016
Q2 		$171K Sell
706
-275
-28% -$72.5K 0.04% 517
2016
Q1 		$255K Sell
981
-957
-49% -$253K 0.07% 438
2015
Q4 		$594K Buy
1,938
+1,150
+146% +$330K 0.17% 247
2015
Q3 		$230K Sell
788
-1,536
-66% -$507K 0.05% 487
2015
Q2 		$939K Buy
2,324
+1,654
+247% +$664K 0.12% 268
2015
Q1 		$283K Buy
670
+644
+2,477% +$254K 0.04% 335
2014
Q4 		$9K Buy
+26
New +$8.41K ﹤0.01% 383

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAM Systematic's BIIB Position: Q3 2017 in Review

GAM Systematic increased its Biogen (BIIB) stake by 46% in Q3 2017, buying an estimated $500K and bringing the position to 5,369 shares worth $1.68M. The position accounts for 0.24% of the portfolio, ranked #149.

GAM Systematic first reported a position in BIIB in Q4 2014 and has held it in 12 quarters since. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • GAM Systematic held 5,369 shares of Biogen worth $1.68M as of Q3 2017.
  • GAM Systematic bought 1,688 Biogen shares in Q3 2017, an estimated $500K.
  • Biogen made up 0.24% of GAM Systematic's portfolio in Q3 2017, its #149 holding.
  • GAM Systematic first reported a position in Biogen in Q4 2014 and has held it in 12 quarters since.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.